[HTML][HTML] Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and …
C Mauz-Körholz, J Landman-Parker, W Balwierz… - The lancet …, 2022 - thelancet.com
Background Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
[HTML][HTML] Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in intermediate-and advanced-stage children and adolescents …
C Mauz-Körholz, J Landman-Parker… - The Lancet …, 2022 - research.ed.ac.uk
BACKGROUND: Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
[PDF][PDF] Christine Mauz-Körholz*, Judith Landman-Parker*, Walentyna Balwierz*, Roland A Ammann, Richard A Anderson, Andische Attarbaschi, Jörg M Bartelt, Auke …
A Uyttebroeck, D Vordermark, D Körholz… - Lancet …, 2022 - scholar.archive.org
Background Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
[PDF][PDF] Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and …
C Mauz-Körholz, J Landman-Parker, W Balwierz… - The lancet …, 2022 - boris.unibe.ch
BACKGROUND Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced …
C Mauz-Korholz, J Landman-Parker, W Balwierz… - The Lancet …, 2022 - ruj.uj.edu.pl
Response-adapted omission of radiotherapy and comparison of consolidation
chemotherapy in children and adolescents with intermediate-stage and advanced-stage …
chemotherapy in children and adolescents with intermediate-stage and advanced-stage …
[PDF][PDF] Christine Mauz-Körholz*, Judith Landman-Parker*, Walentyna Balwierz*, Roland A Ammann, Richard A Anderson, Andische Attarbaschi, Jörg M Bartelt, Auke …
A Uyttebroeck, D Vordermark, D Körholz… - Lancet …, 2022 - lirias.kuleuven.be
Background Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
[HTML][HTML] Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and …
C Mauz-Körholz, J Landman-Parker… - The Lancet …, 2022 - ncbi.nlm.nih.gov
Background Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
[PDF][PDF] Christine Mauz-Körholz*, Judith Landman-Parker*, Walentyna Balwierz*, Roland A Ammann, Richard A Anderson, Andische Attarbaschi, Jörg M Bartelt, Auke …
A Uyttebroeck, D Vordermark, D Körholz… - Lancet Oncol, 2022 - pure.eur.nl
Background Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced …
C Mauz-Körholz, J Landman-Parker… - The Lancet …, 2021 - europepmc.org
Background Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced …
C Mauz-Körholz, J Landman-Parker, W Balwierz… - 2022 - pubmed.ncbi.nlm.nih.gov
Background Children and adolescents with intermediate-stage and advanced-stage
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …
classical Hodgkin lymphoma achieve an event-free survival at 5 years of about 90% after …